Skip to main content
TrendingNews.today
World News
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
As of Mar 23
HealthChina1 sourcesNeutral

LG Chem's Licensed Gout Drug Enters Phase 3 Trials in China

LG Chem said on the 23rd that Innovent Biologics, which holds the Chinese license for the company's gout drug candidate tigulixostat, has dosed the first patient in a Phase 3 clinical trial in China, officially entering the final stage toward commercialization. Innovent will enroll 600 gout patient

PS
park si-eun
via 서울경제
ShareRead original

Read the full article at 서울경제 →

LG Chem's Licensed Gout Drug Enters Phase 3 Trials in China

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

서울경제
서울경제
NewsDataCN

Comments

0 comments
Be respectful and constructive.
Loading comments...
Previous
Entertainment event this week in Knox County: March 22-28
Next
Historic Hawaii floods leave 2,000 people without power

Related Articles

Advocate flags communication gap for deaf JamaicansHealth
Advocate flags communication gap for deaf Jamaicans
Jerome Williams Reporter-4h ago-1 sources
Push for policies to boost medication adherenceHealth
Push for policies to boost medication adherence
Unknown-4h ago-1 sources
Kyorin Inks Global Licensing Deal With UBE For Novel Drug CandidatesHealth
Kyorin Inks Global Licensing Deal With UBE For Novel Drug Candidates
Unknown-8h ago-1 sources